Page last updated: 2024-12-08

cerium phosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

cerium phosphate: intermediate product in cerium-based technique for staining lysosomal enzymes [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID159673
MeSH IDM0138553

Synonyms (23)

Synonym
cerium phosphate
13454-71-2
cerium(3+) phosphate
phosphoric acid,cerium(3+) salt (1:1)
cerium monophosphate
cerium(3 ) phosphate
unii-xr1z4biw2j
xr1z4biw2j ,
cerium orthophosphate (cepo4)
phosphoric acid, cerium(3 ) salt (1:1)
einecs 236-637-8
cerium(iii) phosphate
AKOS025294338
(r)-1,2-propanediaminedihydrochloride
cerium phosphate (cepo4)
phosphoric acid, cerium(3+) salt (1:1)
mfcd00049424
DTXSID10928665
Q26841325
cerium(3+);phosphate
cerium(iii)phosphate
cerium(iii) phosphate sputtering target
cerium(iii) phosphate, 99% min
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (33)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (6.06)18.7374
1990's4 (12.12)18.2507
2000's7 (21.21)29.6817
2010's19 (57.58)24.3611
2020's1 (3.03)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 29.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index29.92 (24.57)
Research Supply Index3.53 (2.92)
Research Growth Index4.96 (4.65)
Search Engine Demand Index33.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (29.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other33 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]